top of page

BackTable / Tumor Board / Podcast / Episode #24

Contemporary Diagnostics in NMIBC: Clinical Insights

with Dr. Anne Schuckman and Dr. Piyush Agarwal

How are leading urologic oncologists using advanced biomarkers and artificial intelligence to refine the diagnosis and management of non-muscle invasive bladder cancer (NMIBC)? In the opening episode of our 2025 NMIBC Creator Weekend™ series, host Dr. Bogdana Schmidt engages in an insightful, in-studio discussion with Dr. Anne Schuckman and Dr. Piyush Agarwal about contemporary strategies and challenges in the diagnosis of non-muscle invasive bladder cancer.

This podcast is supported by:

Be part of the conversation. Put your sponsored messaging on this episode. Learn how.

Contemporary Diagnostics in NMIBC: Clinical Insights with Dr. Anne Schuckman and Dr. Piyush Agarwal on the BackTable Tumor Board Podcast
Ep 24 Contemporary Diagnostics in NMIBC: Clinical Insights with Dr. Anne Schuckman and Dr. Piyush Agarwal
00:00 / 01:04

BackTable, LLC (Producer). (2025, October 7). Ep. 24 – Contemporary Diagnostics in NMIBC: Clinical Insights [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Sign Up:

Podcast Contributors

Dr. Piyush Agarwal on the BackTable Urology Podcast

Dr. Piyush Agarwal is a professor of surgery with The University of Chicago in Illinois.

Dr. Bogdana Schmidt on the BackTable Urology Podcast

Dr. Bogdana Schmidt, MD, MPH, is a urologic surgeon specializing in urologic oncology at the University of Utah in Salt Lake City, Utah.

Dr. Anne Schuckman on the BackTable Urology Podcast

Dr. Anne Schuckman is an associate professor of clinical urology at USC in Los Angeles, California.

Synopsis

The doctors emphasize the importance of having an experienced cytopathologist and discuss the use of different biomarkers and imaging modalities in bladder cancer diagnosis. The conversation delves into risk stratification, patient management strategies, and the evolving role of technology and artificial intelligence in enhancing diagnostic accuracy. The experts also share their perspectives on future advancements and their potential impact on clinical practice.

Timestamps

00:00 - Introduction
04:05 - Surveillance and Follow-Up Strategies
10:10 - Biomarkers in Bladder Cancer
18:02 - Blue Light Cystoscopy and Patient Comfort
30:56 - Risk Assessment and Counseling
42:56 - Future of Bladder Cancer Diagnostics
47:00 - Concluding Thoughts

Resources

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

backtable-plus-vi-cta.jpg
Become a BackTable Sponsor

Up Next

NSCLC Treatment: Bispecific Antibodies & EGFR Mutations with Dr. Wade Iams on the BackTable Tumor Board Podcast
Pulse Electrical Field Ablation: Lung Cancer Applications & Benefits with Dr. William Moore and Dr. Daniel Sterman on the BackTable Tumor Board Podcast
ESMO Update: Advances in Upper GI Malignancies with Dr. Jun Gong and Dr. Jonathan Mizrahi on the BackTable Tumor Board Podcast
ESMO Update: Trial Results & New Therapies in Colorectal Cancer with Dr. Jun Gong and Dr. Jonathan Mizrahi on the BackTable Tumor Board Podcast
NSCLC Tumor Board Discussion: Considerations for Oligometastatic Disease with Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh, Dr. Alan Lee and Dr. Scott Genshaft on the BackTable Tumor Board Podcast
Complex HCC Patients & The "Grey Zone": What To Do When You Don’t Know What To Do with Dr. Adam Burgoyne, Dr. Zach Berman, Dr. Kirema Garcia-Reyes and Dr. Lingling Du on the BackTable Tumor Board Podcast

Articles

Topics

Oncology Podcasts

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

bottom of page